الصفحة الرئيسية>>Peptides>> Amyloid β protein>>(7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40)

(7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40)

رقم الكتالوجGA20024

Amyloid β-protein (1-40) that is N-terminally modified with the fluorescent dye (7-diethylaminocoumarin-3-yl)carbonyl (DAC or DEAC). This derivative can be utilized to assess the binding properties of amyloid β-protein (1-40) for various membranes since it behaves very similar to the native peptide. In aqueous environments the fluorophore is almost non-fluorescent whereas binding to membranes results in an increase in fluorescence intensity (Λex = 430 nm, Λem = 470 nm). Increases in the GM1 ganglioside and cholesterol content in the lipid bilayers facilitated the binding of this peptide. For phosphatidylcholine and phosphatidylserine no affinity was observed.

Products are for research use only. Not for human use. We do not sell to patients.

(7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40) التركيب الكيميائي

Cas No.: 1802087-66-6

الحجم السعر المخزون الكميّة
0.5mg
272٫00
متوفر
1mg
501٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Amyloid β-protein (1-40) that is N-terminally modified with the fluorescent dye (7-diethylaminocoumarin-3-yl)carbonyl (DAC or DEAC). This derivative can be utilized to assess the binding properties of amyloid β-protein (1-40) for various memb

مراجعات

Review for (7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40)

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.